
Journal of Medicinal Chemistry p. 2687 - 2700 (2011)
Update date:2022-07-30
Topics:
Pike, Victor W.
Rash, Karen S.
Chen, Zhaogen
Pedregal, Concepción
Statnick, Michael A.
Kimura, Yasuyuki
Hong, Jinsoo
Zoghbi, Sami S.
Fujita, Masahiro
Toledo, Miguel A.
Diaz, Nuria
Gackenheimer, Susan L.
Tauscher, Johannes T.
Barth, Vanessa N.
Innis, Robert B.
Positron emission tomography (PET) coupled to an effective radioligand could provide an important tool for understanding possible links between neuropsychiatric disorders and brain NOP (nociceptin/orphanin FQ peptide) receptors. We sought to develop such a PET radioligand. High-affinity NOP ligands were synthesized based on a 3-(2′-fluoro-4′,5′- dihydrospiro[piperidine-4,7′-thieno[2,3-c]pyran]-1-yl)-2(2-halobenzyl) -N-alkylpropanamide scaffold and from experimental screens in rats, with ex vivo LC-MS/MS measures, three ligands were identified for labeling with carbon-11 and evaluation with PET in monkey. Each ligand was labeled by 11C-methylation of an N-desmethyl precursor and studied in monkey under baseline and NOP receptor-preblock conditions. The three radioligands, [11C](S)-10a-c, gave similar results. Baseline scans showed high entry of radioactivity into the brain to give a distribution reflecting that expected for NOP receptors. Preblock experiments showed high early peak levels of brain radioactivity, which rapidly declined to a much lower level than seen in baseline scans, thereby indicating a high level of receptor-specific binding in baseline experiments. Overall, [11C](S)-10c showed the most favorable receptor-specific signal and kinetics and is now selected for evaluation in human subjects.
View MoreSINO Industries Company Limited(expird)
Contact:86-29-85369724
Address:No.111, Jiefang Road, Xi’an, China
website:http://www.uvchemkeys.com
Contact:0086-021-58785816
Address:RM2607 Building No.1 Guosheng, Lane 388, Zhongjiang Road, Putuo District, Shanghai 200062 China
Jiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:No.199, Ningbo Avenue, Fengxin industrial park, Fengxin county, Yichun city, Jiangxi
Suzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
lianyungang jinkang pharmaceutical technology co., ltd.
Contact:008651885445517
Address:Jinshan industrial park, Ganyu county, Lianyungang, Jiangsu Province, 222115, China
Doi:10.1016/S0960-894X(00)00002-0
(2000)Doi:10.1016/S0040-4039(99)00381-0
(1999)Doi:10.1021/om980957z
(1999)Doi:10.1021/jo9902751
(1999)Doi:10.1081/SCC-120024745
(2003)Doi:10.1134/S0012500812090066
(2012)